The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 768-773

  Kim, AeRang ^a,g   Ji, Lingyun ^b   Balmaceda, Casilda ^c   Diez, Blanca ^d   Kellie, Stewart J ^e   Dunkel, Ira J ^f   Gardner, Sharon L ^a   Sposto, Richard ^b   Finlay, Jonathan L ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d FLENI   (Argentina)

^e UNIVERSITY OF SYDNEY   (Australia)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Germ cell tumors; Pediatric neuro oncology; Survival; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CLINICAL TRIAL; FEMALE; GERM CELL TUMOR; HAZARD RATIO; HISTOLOGY; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SERUM; TREATMENT RESPONSE;

ADOLESCENT; ALPHA-FETOPROTEINS; BRAIN NEOPLASMS; CHILD; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 56749103063     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21741     Document Type: Article

References (27)

1. Balmaceda C, Finlay J. Current advances in the diagnosis and management of intracranial germ cell tumors. Curr Neurol Neurosci Rep 2004;4:253-262.
2. Smith AA, Weng E, Handler M, et al. Intracranial germ cell tumors: A single institution experience and review of the literature. J Neurooncol 2004;68:153-159.
3. Schneider DT, Calaminus G, Gobel U. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood. Pediatr Hematol Oncol 2001;18:11-26.
4. Picozzi VJ, Jr., Freiha FS, Hannigan JF, Jr., et al. Prognostic significance of a decline in serum human chorionic gonadotropin levels after initial chemotherapy for advanced germ-cell carcinoma. Ann Intern Med 1984;100:183-186.
5. Baranzelli MC, Patte C, Bouffet E, et al. Nonmetastatic intracranial germinoma: The experience of the French Society of Pediatric Oncology. Cancer 1997;80:1792-1797.
6. Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation-a novel approach for newly diagnosed CNS germ cell tumors: Results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 1996;14:2908-2915.
7. Calaminus G, Bamberg M, Harms D, et al. AFP/beta-HCG secreting CNS germ cell tumors: Long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 2005;36:71-77.
8. Kellie SJ, Boyce H, Dunkel IJ, et al. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: Results of the second international CNS germ cell study group protocol. J Clin Oncol 2004;22:846-853.
9. Kellie SJ, Boyce H, Dunkel IJ, et al. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: Failure of a primary chemotherapy approach. Pediatr Blood Cancer 2004;43:126-133.
10. Kalbfleish J, Prentice R. The statistical analysis of failure time data. New York, NY: Wiley; 1980.
11. International Germ Cell Consensus. Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
12. Choi JU, Kim DS, Chung SS, et al. Treatment of germ cell tumors in the pineal region. Childs Nerv Syst 1998;14:41-48.
13. Kretschmar C, Kleinberg L, Greenberg M, et al. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: A report from the children's oncology group. Pediatr Blood Cancer 2006;48:285-291.
14. Oka H, Kawano N, Tanaka T, et al. Long-term functional outcome of suprasellar germinomas: Usefulness and limitations of radiotherapy. J Neurooncol 1998;40:185-190.
15. Sawamura Y, Ikeda J, Shirato H, et al. Germ cell tumours of the central nervous system: Treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 1998;34:104-110.
16. Calaminus G, Bamberg M, Baranzelli MC, et al. Intracranial germ cell tumors: A comprehensive update of the European data. Neuropediatrics 1994;25:26-32.
17. Cuccia V, Galarza M. Pure pineal germinomas: Analysis of gender incidence. Acta Neurochir (Wien) 2006;148:865-871 discussion 871.
18. Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases. J Neurosurg 1997;86:446-455.
19. Ogino H, Shibamoto Y, Takanaka T, et al. CNS germinoma with elevated serum human chorionic gonadotropin level: Clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 2005;62:803-808.
20. Sano K. Pathogenesis of intracranial germ cell tumors reconsidered. J Neurosurg 1999;90:258-264.
21. Yoshida J, Sugita K, Kobayashi T, et al. Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 1993;120:111-117.
22. Shibamoto Y, Takahashi M, Sasai K. Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:505-510.
23. Sawamura Y, Shirato H, Ikeda J, et al. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 1998;88:66-72.
24. Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: Natural history and pathogenesis. J Neurosurg 1985;63:155-167.
25. Nishizaki T, Kajiwara K, Adachi N, et al. Detection of craniospinal dissemination of intracranial germ cell tumours based on serum and cerebrospinal fluid levels of tumour markers. J Clin Neurosci 2001;8:27-30.
26. Baranzelli MC, Kramar A, Bouffet E, et al. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 1999;17:1212.
27. Mazumdar M, Bajorin DF, Bacik J, et al. Predicting outcome to chemotherapy in patients with germ cell tumors: The value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 2001;19:2534-2541.